Pacira BioSciences Inc
PCRX
Market Cap$1.2B
Close$
$58.75
122.1% upside
Current Fair Value
122.1% upsideUndervalued by 122.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.20 Billion |
|---|---|
| Enterprise Value | $1.53 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.15 |
| Beta | 0.48 |
| Outstanding Shares | 45,459,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -9.51 |
|---|---|
| PEG | 7.57 |
| Price to Sales | 1.76 |
| Price to Book Ratio | 1.65 |
| Enterprise Value to Revenue | 2.17 |
| Enterprise Value to EBIT | -15.96 |
| Enterprise Value to Net Income | -12 |
| Total Debt to Enterprise | 0.41 |
| Debt to Equity | 0.83 |
Revenue Sources
No data
Insider Trades
ESG Score
No data